Rafina Innovations Inc. Announces Brand-New Website and Exclusive Distributor Agreement with OPTEC International Inc.
Rafina Innovations (OTC PINK: VICA) has officially launched its new website, which aims to enhance user experience and accessibility to company information. Additionally, Rafina has secured an Exclusive Distribution Agreement with OPTEC International, Inc. for the distribution of their PPE products in Cyprus. This partnership is expected to boost sales and revenue streams. The company is focused on growth in prosthetics and rehabilitation markets, leveraging advanced technologies to maintain high margins.
- Launch of a new, user-friendly website.
- Exclusive distribution agreement with OPTEC International for PPE in Cyprus, expected to boost sales.
- Focus on high-growth prosthetics and rehabilitation markets.
- None.
Nicosia, Cyprus, May 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Rafina Innovations Inc. (OTC PINK: VICA), a Medical and Pharmaceutical development company, is pleased to officially announce the launch of its brand-new website and domain, designed with a user-friendly navigation, updated with the latest information and topics about its products and services. Its company goal with the new website is to provide its customers and shareholders an easier way to learn about the company. Rafina’s team will be constantly updating the company’s content with helpful information, articles and company announcements. https://www.vicahub.com
Rafina Innovations Inc.is pleased to announce that it has entered into an Exclusive Distribution Agreement with OPTEC International, Inc., a developer of UV and UV-C safety products using related advanced technologies specific to Personal Protection Equipment (PPE), and supplier of wholesale Medical PPE (OTC PINK: OPTI), for Cyprus. Rafina will enjoy an exclusive right to distribute all OPTEC product lines. https://optecintl.com
Constantinos Zertalis, Rafina’s Chairman, President and CEO, commented: "We at Rafina Innovations, Inc. are excited to announce the launch of our Brand-New Website and the signing of the Exclusive Distribution Agreement with OPTEC International which will definitely help us to increase sales and will have a positive impact on our revenue streams that will help the company to go to the next level.”
OPTEC International CEO, Roger Pawson, stated: “We are very happy to have Rafina as an exclusive distributor for the Cyprus territory to expand our product lines to this medical/pharmaceutical region and particularly in the Ocean-Going Vessel Shipping sectors. We look forward to further expanding our cooperation with Rafina in this region.”
About Rafina Innovations Inc.
Rafina Innovations Inc. is a development capital investment opportunity in the high growth / high margin prosthetics, orthotics, rehabilitation, and diabetes markets. It benefits from a market leading footing from which to expand and seeks to invest in a synergistic business model of Rafina Innovations Clinics and new technology development, with an out-licensing model. The company has a strong pipeline of near-market to research-stage technologies, developed by a team that includes world-renowned experts in their field, each committed to the company on an on-going basis.
The Rafina Innovations Clinics can be early adopters of the technologies and provide the springboard for further innovation, as well as opportunities for lower-cost clinical trials. This synergistic model will allow the company to sustain high margins and accelerate revenue growth as both the number of clinics and products grow.
About C-Pharm Ltd
C-PHARM is a leading distributor for medical supplies and equipment striving to supply the world with everything needed. High Standards, Affordable Packages, Private Agreements, top quality and support are some of the words that define us, as a Company.
About OPTEC International, Inc.
With Locations in Carlsbad and Vista, California, OPTEC International is a developer and manufacturer of electronic LED, Ultraviolet (UV) & UV-C safety products and related advanced technologies and PPE (Personal Protection Equipment) products. The company's Safe-Scan product line is being launched at a time when HR directors and facilities managers are experiencing extreme concern with respect to keeping environments safe during the global pandemic crisis and the safe reopening of the U.S. economy. For more information, visit: www.optecintl.com
Safe Harbor Statement: Safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as Opti, OPTEC or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions, or goals also are forward- looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. OPTEC International Inc.
Please visit: https://www.vicahub.com/ https://c-pharm.org/
Forward Looking Statements
This press release contains forward-looking statements. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as "expects", "intends", "estimates", "projects", "anticipates", "believes", "could", and other similar words. All statements addressing product performance, events, or developments that the Company expects or anticipates will occur in the future are forward-looking statements, including but not limited to future developments in the areas of athletic shoes and the information and performance of the Company's technology in such applications. Because the statements are forward-looking, they should be evaluated considering important risk factors and uncertainties, some of which are described in the Company's Quarterly, Annual and Current Reports filed with the OTC. Should one or more of these risks or uncertainties materialize or should any of the Company's underlying assumptions prove correct, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on Company's forward-looking statements. In particular, the Company has acquired its first operational Prosthetics & Orthotics (P&O) clinic and is continuing development efforts for its other biomedical technologies, including a "smart insole" and its Flexisense™ sensing technology with several potential applications. There is no assurance that the Company will be successful in its ongoing expansion and development efforts, or that it will find suitable commercialization partners for its technologies. Except as required by law, Rafina Innovations Inc. disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. No stock exchange, securities commission or other regulatory body has reviewed nor accepts responsibility for the adequacy or accuracy of this release. Investors are advised to carefully review the reports and documents that Rafina Innovations files from time to time with the OTC, including its Annual, Quarterly and Current Reports.
For Investors Relations:
Website: www.vicahub.com , www.rafina-innovations.com
Email: info@rafinainnovations.com
SOURCE: Rafina Innovations Inc.
FAQ
What is the latest news from Rafina Innovations (VICA)?
How will the new website benefit Rafina Innovations' shareholders?
What products will Rafina Innovations distribute under the new agreement?
What impact is expected from Rafina's agreement with OPTEC International?
What markets does Rafina Innovations focus on?
